Clinical Use of EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting in Gulf Cooperation Council Countries

Safety and Immunogenicity of Malaria Vaccines AdCh63 AMA1, MVA AMA1 and AMA1-C1/Alhydrogel®+/- CPG 7909

NCT01351948 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Efficacy Study of ChAd63/MVA METRAP + RTS,S

NCT01883609 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Chemoprophylaxis and Plasmodium Falciparum NF54 Sporozoite Immunization Challenged by Heterologous Infection

NCT02098590 ·Status: COMPLETED ·Phase: NA

A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2

NCT03203421 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess the Safety and Immunogenicity of a Candidate Malaria Vaccine Using Novel Routes of Administration

NCT03084289 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety of Fractional Booster Dose of COVID-19 Vaccines Available for Use in Pakistan/Brazil: A Phase 4 Dose-optimizing Trial

NCT05343871 ·Status: COMPLETED ·Phase: PHASE4

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria

NCT07235020 ·Status: COMPLETED ·Phase: PHASE2

Title: Recombinant Plague Vaccine rF1V in Healthy Volunteers

NCT00332956 ·Status: COMPLETED ·Phase: PHASE2

Malaria Infection Diagnosed by Polymerase Chain Reaction (PCR) as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines

NCT00121823 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of a Single Doses of MMV533.

NCT04323306 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Efficacy Study of Concomitant Administration of ChAd63/MVA ME-TRAP + RTS,S

NCT02252640 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkina Faso

NCT01018459 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of AdCh63 ME-TRAP and MVA ME-TRAP Vaccines in Malaria Endemic Areas

NCT01379430 ·Status: COMPLETED ·Phase: PHASE1

Regimen Optimization Trial of PfSPZ Vaccine in Equatorial Guinea

NCT03590340 ·Status: COMPLETED ·Phase: PHASE1

Assessment of Immunogenicity, Safety and Reactogenicity of a Booster Dose of Various COVID-19 Vaccine Platforms in Individuals Primed With Several Regimes.

NCT05812586 ·Status: UNKNOWN ·Phase: PHASE3

Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in Children

NCT03534245 ·Status: COMPLETED

Reproducibility of Malaria Challenge in Healthy Volunteers

NCT01058226 ·Status: COMPLETED ·Phase: PHASE1

A Phase I/IIa Sporozoite Challenge Study to Assess the Efficacy of Candidate Combination Malaria Vaccine Approaches Using the ChAd63 and MVA Vectors Encoding the Antigens ME-TRAP, CS and AMA1

NCT01739036 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess the Effectiveness of a New Malaria Vaccine Candidate by Infecting Vaccinated Volunteers With Malaria Parasites

NCT00890760 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Diagnosis and Treatment of Leishmania Infections

NCT00344188 ·Status: RECRUITING

Safety and Efficacy of NF135 CPS Immunization

NCT03813108 ·Status: TERMINATED ·Phase: NA

Safety Study of Dengushield in Healthy Adults

NCT03883620 ·Status: COMPLETED ·Phase: PHASE1

A Challenge Study to Assess the Blood-stage Efficacy of Full-length SUM-101 Malaria Vaccine Candidate

NCT07124156 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Clinical Trial to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 Pfs25-IMX313 and MVA Pfs25-IMX313

NCT02532049 ·Status: COMPLETED ·Phase: PHASE1

Malaria Challenge in Healthy Volunteers

NCT01500980 ·Status: COMPLETED ·Phase: PHASE1